TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CWK

CWK

Cushman & Wakefield Ltd.

Next earnings Aug 3, 2026 · consensus $0.35 EPS, $2.67B rev

Last earnings -4.2% on 2026-05-07

Buy
$13.99
▲ +1.82%
$13.99▲ +25.70%
over 1Y
L $11.07H $17.20
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.8%
1W+7.6%
1M+6.6%
3M+12.1%
YTD-11.7%
1Y+25.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C
Valuation
Overvalued
Filings
Watch
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 15 analysts
Buy

Cyclical CRE-services recovery hidden by a one-time impairment — operating income, EBITDA and cash flow all surged while debt fell.

Revenue (FY2025) $10.3B · FY2025

The read

The fundamentals carry the rating, but the price is rich (~82% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

The headline scares — net income fell 33% to $88.2M and EPS dropped to $0.38, putting the P/E at a rich-looking 36x. But the MD&A tells you that decline is almost entirely a single non-cash event: a $177.0M other-than-temporary impairment on the Greystone JV. Strip the optics and the underlying engine accelerated — operating income rose 33.5% to $453M, Adjusted EBITDA rose 13% to $656.2M, and operating cash flow jumped 63.7% to $340.4M. Revenue grew 8.9% to $10.3B with every service line up: Capital markets +19%, Leasing +8%, Valuation +9%, Services +4%. Capital-markets re-acceleration is the classic early-cycle tell for commercial real estate, and management frames 2025 as a 'higher number of brokerage transactions' year as rates and credit conditions thaw.

The balance sheet is moving the right way. Management completed three Term Loan repricings (lowest credit spread in company history), voluntarily prepaid $300M of principal, cut long-term debt 10.7% to $2.62B, grew equity 11.4%, and ended with $1.8B of liquidity ($1.0B undrawn revolver + $0.8B cash). Leverage at 2.93x liabilities/equity is still high and the -$898M accumulated deficit reflects past pain, but the direction is deleveraging into a recovery, not stress. On valuation, the 0.3x P/S is the more honest lens for an asset-light, fee-based services firm than a one-year impaired P/E; you are paying very little for a $10.3B revenue franchise whose normalized earnings power (FY2024 delivered $0.56 EPS without this year's charge) is well above the reported $0.38.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 6:38 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$9.39B$10.1B$9.49B$9.45B$10.3B
Gross profit—————
Operating income$497M$535M$206M$339M$453M
Net income$250M$196M-$35.4M$131M$88.2M
Diluted EPS$1.10$0.86-$0.16$0.56$0.38
Net margin2.7%1.9%-0.4%1.4%0.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.24B
EV / EBITDA9.4
EV / Sales0.5
EV / FCF17.9
P / FCF11.2
PEG (trailing)—
Earnings yield2.7%
FCF yield8.9%

Quality & risk

ROIC (est.)7.6%
Free cash flow$293M
Total debt$2.74B
Net cash-$1.96B
Altman Z-Score1.75 distress
Piotroski F-Score5/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Material agreement2026-06-15

    Entered material agreement + new debt obligation (1.01/2.03); likely term-loan refinancing

  2. 8-K Other event2026-06-04

    Other-events disclosure (item 8.01); no financial impact specified

  3. 8-K Other event2026-05-15

    Other-events disclosure (item 8.01); no financial impact specified

  4. 8-K Officer / director change2026-05-14

    Annual meeting vote results + board/exec change (5.07/5.02); routine governance

  5. 8-K Earnings results2026-05-07

    Q1 2026 results (period Mar 31); latest interim filing

  6. 10-Q Quarterly report2026-05-07

    Q1 2026 results (period Mar 31); latest interim filing

  7. 8-K Other event2026-05-04

    Other-events disclosure (item 8.01); no financial impact specified

  8. DEF 14A Proxy statement2026-04-03
  9. 10-K Annual report2026-02-19

    FY25 rev +9% to $10.3B, Adj EBITDA +13%; net income -33% on $177M Greystone JV impairment

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-122026-06-15open ↗4Period ending 2026-06-042026-06-08open ↗144Filing2026-06-04open ↗SCHEDULE 13GFiling2026-06-04open ↗8-KPeriod ending 2026-06-042026-06-04open ↗4Period ending 2026-06-012026-06-02open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗4Period ending 2026-05-142026-05-18open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueB-
GrowthD
ProfitabilityC-
Financial healthB-
MomentumC
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$2.49

Overvalued -82% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.38 × (8.5 + 1.5 × 0.0% growth) × 0.77 quality = 6.5× multiple. An estimate, not a price target.

11.0952-week17.20
Revenue
$10.3B
+8.9% YoY
Net margin
0.9%
ROE
4.5%
P/E
36.8

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$10.3B+8.9%
Net income$88.2M-32.8%
Operating income$453M+33.5%
Diluted EPS$0.38-32.1%
Cash & equivalents$784M-1.1%
Total assets$7.68B+1.7%
Total liabilities$5.72B-1.3%
Stockholders' equity$1.96B+11.4%
Op.: 4.4%L/E: 2.93x

Frequently asked

Is Cushman & Wakefield Ltd. (CWK) a buy?
CWK currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Cyclical CRE-services recovery hidden by a one-time impairment — operating income, EBITDA and cash flow all surged while debt fell.
What is CWK's fair value?
A Modified-Graham model based on CWK's SEC fundamentals estimates a fair value of about $2.49. It is an estimate from reported earnings, not a price target.
Is CWK overvalued or undervalued?
Against a Modified-Graham fair-value estimate, CWK currently appears overvalued relative to its SEC-grounded earnings power.
What is Cushman & Wakefield Ltd.'s quality score?
CWK scores 57.83989248541418/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001628369, latest 10-Q filed 2026-05-07) · EODHD · Proprietary analysis · as of 6/29/2026, 10:38:00 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 1 sale

2026-06-04
Robinson Nathaniel
See Remarks
Sell24.8K @ $13.25$329K
2026-06-01
FELMAN MICHELLE
Director
Gift17.0K
2026-06-01
FELMAN MICHELLE
Director
Gift17.0K
2026-05-15
FELMAN MICHELLE
Director
Exercise17.0K
2026-05-15
Williamson Billie Ida
Director
Exercise17.0K
2026-05-15
McLean Jodie W.
Director
Exercise17.0K

Earnings history

beat/miss · move
2026-05-07Beat +11.4% est▼ -4.22%8-K ↗
2026-02-19Miss -0.8% est▼ -3.17%8-K ↗
2025-10-30Beat +2.8% est▼ -2.12%8-K ↗
2025-08-05Beat +35.7% est▲ +8.69%8-K ↗
2025-04-29—▲ +4.44%8-K ↗
2025-02-20—▼ -5.99%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2023-05-19Daniel GoldmanSell$1.00K–$15.0KPTR ↗
2022-12-29Susie LeeSell$1.00K–$15.0KPTR ↗
2021-07-13Susie LeeBuy$1.00K–$15.0KPTR ↗
2021-07-13Susie LeeBuy$1.00K–$15.0KPTR ↗
2021-07-13Susie LeeBuy$1.00K–$15.0KPTR ↗
2021-07-13Susie LeeBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
How New Capital Markets Leaders and Index Shift Will Impact Cushman & Wakefield (CWK) InvestorsBullish
finance.yahoo.com· 2026-07-01
Cushman & Wakefield (CWK) Stock After Real Estate Sector Reassessment Of Future ProspectsBullish
finance.yahoo.com· 2026-06-30
Cushman & Wakefield Releases 2025 Sustainability ReportBullish
finance.yahoo.com· 2026-06-30
Cushman & Wakefield (CWK) Surges 5.0%: Is This an Indication of Further Gains?Bullish
finance.yahoo.com· 2026-06-29
Fast-paced Momentum Stock Cushman & Wakefield (CWK) Is Still Trading at a BargainBullish
finance.yahoo.com· 2026-06-29
How Much Upside is Left in Cushman & Wakefield (CWK)? Wall Street Analysts Think 36.15%Bullish
finance.yahoo.com· 2026-06-26

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score58 vs 67
Revenue growth8.9% vs 7.5%
Net margin0.9% vs 10.0%
Return on equity4.5% vs 12.0%
P/E36.8 vs 26.2

News sentiment

EODHD · 35d
Bullish
+0.18
vs typical · 58 articles

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.